The Society’s Metabolic and Obesity Network and Obesity Management Collaborative UK have joined together to publish a joint statement regarding medical therapies for obesity. Read here. 

Read the NIHR Health and Care Research alert on the safety of testosterone treatment, which is based on Adverse cardiovascular events and mortality in men during testosterone treatment: an individual patient and aggregate data meta-analysis (The Lancet, 2022) 

Guidelines on the evaluation and management of primary hyperparathyroidism and hypoparathyroidism (Journal of Bone and Mineral Research, 2022)

European Society of Endocrinology clinical practice guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors. (October 2018)

Tasks and responsibilities for prevention programs targeting iodine deficiency disorders. 

National Osteoporosis Society physical activity, exercise and osteoporosis consensus statement and quick guide.

National Osteoporosis Society vitamin D guidelines and quick guide.

Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. (August 2018)

Guidance for the assessment and management of prostate cancer treatment-induced bone loss. A consensus position statement from an expert group. (December 2018)

One page guides to help GPs treat pituitary insufficiency, ovarian insufficiency, testicular
insufficiency, bone health, thyroid problems and hot flushes when HRT
is contraindicated. 

Effective secondary prevention of fragility fractures: clinical standards for fracture liaison services.

A position statement by the British Thyroid Association Executive Committee. (May 2015) 

American Association of Clinical Endocrinologists position statement.

The Society endorses this position statement on the recognition of obesity as a disease. (October 2018)

British Skull Base Society Clinical Consensus Document on Management of Head and Neck Paragangliomas.